|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Nocimed Announces Recent Patent Issuances in United States & Australia
1/9/2013 9:39:15 AM
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Nocimed, LLC is pleased to announce that U.S. patent number 8,344,728 for “Systems and Methods Using Nuclear Magnetic Resonance (NMR) Spectroscopy to Evaluate Pain and Degenerative Properties of Tissue” was issued by the United States Patent and Trademark Office (USPTO) on January 1, 2013. Another patent in a related “family” to this issued U.S. patent was also recently granted in Australia. Other related patent applications are also currently pending in other major international territories outside of the United States. These issued patents and pending patent applications are owned by The Regents of the University of California (UC) via the original inventors at UC San Francisco, and are exclusively licensed to Nocimed, LLC. O’Banion & Ritchey, LLP, including via Cullens Patent & Trade Mark Attorneys in Australia, represented UC in prosecuting these patents to these successful grants. Nocimed is also represented by Knobbe Martens Olson & Bear, LLP in its intellectual property affairs.
|
|
|
|
|
|
|
|
|
|
|